Mephedrone Immunoassay Antibody Detection Kit
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current analytical methods for detecting and determining mephedrone and its metabolites are costly and impractical for clinical and forensic use, lacking a cost-effective and portable solution.
Innovation Solution
Development of an immunoassay using novel antibodies that bind to mephedrone and its metabolites, incorporating immunogens and conjugates for detection and quantification in in vitro samples, offering a compact and portable format for field use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If GC-MS and NMR methods are used to detect mephedrone, then measurement precision is improved, but device complexity and cost increase
Solution Approach 1:
The patent replaces complex mechanical instrumentation systems (GC-MS, NMR) with a biochemical detection system based on antibody-antigen interaction. The immunoassay uses labeled antibodies that bind to mephedrone, enabling detection through simple colorimetric or fluorescent readout rather than complex chromatographic or spectroscopic equipment.
Solution Approach 2:
The patent employs disposable test kits containing pre-coated antibodies and substrates that can be used once and discarded. This eliminates the need for expensive, maintainable analytical instruments and reduces operational complexity while maintaining adequate detection precision for forensic and clinical applications.
2Measurement precision
If GC-MS and NMR methods are used to detect mephedrone, then measurement precision is improved, but cost increases
Solution Approach 1:
The immunoassay test kits use inexpensive components including synthetic antibodies, plastic microplate wells, and cheap substrates that can be manufactured at low cost and disposed of after single use. This dramatically reduces the financial barrier to entry compared to purchasing, maintaining, and operating GC-MS or NMR equipment.
Solution Approach 2:
The patent substitutes expensive mechanical instrumentation with a biochemical detection system that requires minimal infrastructure. The assay reads out through simple optical detection (color change or fluorescence) that can be performed with basic laboratory equipment or even handheld devices, eliminating the need for costly analytical instruments.
3Reliability
If traditional analytical methods are used, then detection capability is improved, but ease of operation deteriorates
Solution Approach 1:
The patent divides the detection system into discrete, user-friendly components: sample application well, antibody-coated detection elements, substrate layers, and readout mechanisms. This modular design allows users to perform simple sequential steps without needing to understand or operate complex analytical instrumentation, while maintaining reliable detection through controlled biochemical reactions.
Solution Approach 2:
The immunoassay kit is designed to be self-contained with all necessary reagents, controls, and instructions integrated into a single unit. The test performs automatic sample processing, antibody binding, and signal generation without requiring external equipment or skilled operation, enabling users to obtain reliable detection results through straightforward follow-the-instructions procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The immunoassay provides a cost-effective, practical, and efficient means for detecting and quantifying mephedrone and its metabolites, surpassing traditional methods like GC-MS and NMR in ease of use and portability.
Implementation Method 1
an antibody that binds to mephedrone, mephedrone metabolites, and compounds comprising the 2-methylamino-1-phenylpropan-1-one structure
Data Source
AI summary
The invention relates to an immunoassay method and kit for the detection and/or the determination of mephedrone, mephedrone metabolites and related compounds. The invention is underpinned by a novel antibody, derived from a novel immunogen, that is sensitive and binds to mephedrone, mephedrone metabolites and related compounds.